Basic Information
| LncRNA/CircRNA Name | PVT1 |
| Synonyms | PVT1, LINC00079, MYC, NCRNA00079, onco-lncRNA-100 |
| Region | GRCh38_8:127794533-128101253 |
| Ensemble | ENSG00000249859 |
| Refseq | NR_003367 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | rectal adenocarcinoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | rectal adenocarcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | HULC,CRNDE and PVT1 expression levels were increased, and the expression level of ADAMTS9 AS5 was decreased in READ tumor tissues compared to adjacent non tumor tissues. |
| Pubmed ID | 29512732 |
| Year | 2018 |
| Title | Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma. |
External Links
| Links for PVT1 | GenBank HGNC NONCODE |
| Links for rectal adenocarcinoma | OMIM COSMIC |